Table 3 Primary and secondary outcome measures
Variables & Arms | Baseline M (SD) | Post-treatment (Booster, 12 wks) M (SD) | p | d (95% CL) | 6-month Follow-up M (SD) | p | d (95% CL) |
|---|---|---|---|---|---|---|---|
Acceptance (CPAQ) | |||||||
 FACT-CP Arm (n = 13) | 61.39 (15.1) | 61.7 (18) | 0.512 | 0.18 (− 0.37, 0.73) | 70.6 (17.52) | 0.049 | 0.55 (0.00, 1.10) |
 ETAU Arm (n = 13) | 60.39 (18.53) | 56.23 (21.37) | 0.147 | −0.40 (− 0.95, 0.15) | 55.39 (19.7) | 0.082 | − 0.49 (− 1.04, 0.06) |
 Between-group differences | – | – | 0.145 | 0.58 (− 0.20, 1.35) | – | 0.009 | 1.04 (0.26, 1.82) |
Disability (ODI) | |||||||
 FACT-CP Arm (n = 13) | 38.02 (16.76) | 28.89 (18.25) | 0.002 | −0.89 (−1.44, − 0.34) | 31.53 (17.14) | 0.023 | −0.64 (− 1.19, − 0.09) |
 ETAU Arm (n = 13) | 43.57 (13.62) | 38.12 (17.8) | 0.003 | − 0.84 (− 1.39, − 0.29) | 42.47.48 (20.60) | 0.55 | −0.17 (− 0.72, 0.38) |
 Between-group differences | – | – | 0.675 | − 0.17 (− 0.94, 0.61) | – | 0.196 | −0.51 (− 1.29, 0.27) |
Values/Action Discrepancy (CPVI) | |||||||
 FACT-CP Arm (n = 13) | 1.73 (0.71) | 0.87 (0.87) | 0.0003 | − 1.04 (− 1.59, − 0.49) | 1.15 (0.85) | 0.013 | − 0.70 (− 1.25, − 0.15) |
 ETAU Arm (n = 13) | 2.34 (0.77) | 1.52 (0.81) | 0.0009 | − 0.94 (− 1.49, − 0.39) | 1.90 (0.90) | 0.068 | −0.51 (− 1.06, 0.04) |
 Between-group differences | – | – | 0.634 | − 0.19 (− 0.96, 0.59) | – | 0.545 | −0.24 (− 1.02, 0.54) |